Suchergebnis | Hamburg Open Science

Facetten

45 Einträge gefunden

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?
2010 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
2008 - Forschungsinformationssystem des UKE
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
[Technical aspects of nerve sparing during retropubic prostatectomy]
2007 - Forschungsinformationssystem des UKE
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
2007 - Forschungsinformationssystem des UKE
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
2007 - Forschungsinformationssystem des UKE
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
2007 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
2007 - Forschungsinformationssystem des UKE
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy.
2006 - Forschungsinformationssystem des UKE
Development and internal validation of preoperative transition zone prostate cancer nomogram.
2006 - Forschungsinformationssystem des UKE
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
2006 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

[Technical aspects of nerve sparing during retropubic prostatectomy]

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.

Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy.

Development and internal validation of preoperative transition zone prostate cancer nomogram.

Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.